:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/22005470/10633735b516dc63da72b54e77a3bf47_wm.png)
Cost-effectiveness of computed tomography screening for lung cancer in the United States.
Summary: Lung cancer screening with CT scans saves lives, but is it worth the high cost to the healthcare system? A major simulation study reveals a surprising twist: the financial value of screening depends almost entirely on whether the patient quits smoking. If the screening process encourages a patient to quit, the cost-effectiveness is excellent. However, if the patient continues to smoke—or smokes more because they feel "safe" after a clear scan—the benefits are nearly erased. Ultimately, screening works best when paired with aggressive support to help patients stop smoking for good.
Tags
Lung Neoplasms
Neoplasms